StealTHY: An immunogen-free CRISPR platform to expose concealed metastasis regulators in immunocompetent models
{{output}}
CRISPR screens have become standard gene discovery platforms in various contexts, including cancer. Yet commonly available CRISPR-Cas9 tools are increasingly recognized as unfit for in vivo investigations in immunocompetent contexts, due to broad immunogenicit... ...
